相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy
Xiaoming Zhong et al.
MOLECULAR CANCER (2020)
Heterogeneous Expression of Programmed Death Receptor-ligand 1 on Circulating Tumor Cells in Patients With Lung Cancer
Yasuhiro Koh et al.
CLINICAL LUNG CANCER (2019)
Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis
Shiyou Wei et al.
JAMA SURGERY (2019)
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
Melanie Janning et al.
CANCERS (2019)
Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human EGFR-mutated Lung Cancers and HER2 Gene-amplified Gastric Cancers in Mice
Akihiro Ito et al.
ANTICANCER RESEARCH (2019)
Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma
Diego de Miguel-Perez et al.
CANCERS (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
Laura Keller et al.
NATURE REVIEWS CANCER (2019)
Circulating tumor cell isolation, culture, and downstream molecular analysis
Sandhya Sharma et al.
BIOTECHNOLOGY ADVANCES (2018)
Longitudinal monitoring reveals dynamic changes in circulating tumor cells (CTCs) and CTC-associated miRNAs in response to chemotherapy in metastatic colorectal cancer patients
Karen Tan et al.
CANCER LETTERS (2018)
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: Results From the CA209-003 Study
Scott Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
Nicolas Guibert et al.
LUNG CANCER (2018)
Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer
Manjima Dhar et al.
SCIENTIFIC REPORTS (2018)
Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer
Masaki Hashimoto et al.
JOURNAL OF THORACIC DISEASE (2018)
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer
Galatea Kallergi et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy
Chunyan Yue et al.
ONCOIMMUNOLOGY (2018)
Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
Aaron Beasley et al.
JCO PRECISION ONCOLOGY (2018)
Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models
Yayoi Adachi et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer
Louise Carter et al.
NATURE MEDICINE (2017)
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape
Malte Mohme et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer
Ren Zhao et al.
ONCOTARGET (2017)
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Leora Horn et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients
Satomi Yagi et al.
PLOS ONE (2017)
Predictive impact of PD-L1-expressing circulating tumor cells in NSCLC patients treated with nivolumab
Ryota Shibaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy
Daniel L. Adams et al.
CLINICAL CANCER RESEARCH (2017)
Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples
David Casadevall et al.
CLINICAL LUNG CANCER (2017)
Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma
A. Strati et al.
ANNALS OF ONCOLOGY (2017)
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Rodrigo Dienstmann et al.
NATURE REVIEWS CANCER (2017)
Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
Yilin Li et al.
BRITISH JOURNAL OF CANCER (2016)
Predictive biomarkers for programmed death-1/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancer
Jordi Remon et al.
CURRENT OPINION IN ONCOLOGY (2016)
The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis
Pedro N. Aguiar et al.
IMMUNOTHERAPY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
Chiara Nicolazzo et al.
SCIENTIFIC REPORTS (2016)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Frequent expression of PD-L1 on circulating breast cancer cells
Martine Mazel et al.
MOLECULAR ONCOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Epithelial-Mesenchymal Transitioned Tumor Cells Capture for Detecting Tumor Progression
Arun Satelli et al.
CLINICAL CANCER RESEARCH (2015)
Microcavity Array System for Size-Based Enrichment of Circulating Tumor Cells from the Blood of Patients with Small-Cell Lung Cancer
Masahito Hosokawa et al.
ANALYTICAL CHEMISTRY (2013)
Cisplatin influences acquisition of resistance to molecular-targeted agents through epithelial-mesenchymal transition-like changes
Maki Kurokawa et al.
CANCER SCIENCE (2013)
Size-Based Isolation of Circulating Tumor Cells in Lung Cancer Patients Using a Microcavity Array System
Masahito Hosokawa et al.
PLOS ONE (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Circulating Tumor Cells and Sample Size: The More, the Better
Zarina S. Lalmahomed et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
分享论文
